The UK has reported 25 new cases of rare blood clots possibly linked to AstraZeneca Plc’s Covid-19 vaccine, adding to numbers that have prompted some European countries to adopt precautionary measures.
The new reports bring the total number of cases to March 30 to March 24, the Medicines and Health Products Regulatory Agency said in a statement on Thursday. The benefits of the shot continue to outweigh the risks, the regulator said.
AstraZeneca’s vaccine, developed with the University of Oxford, is under increasing scrutiny and has faced waning support in Europe. Yet countries are counting on the vaccine to help them emerge from the pandemic, and millions of doses have been administered across the region.
The UK agency said the 30 incidents were out of 18.1 million doses of AstraZeneca vaccine administered before March 24. Previously, the agency had revealed five cases on March 18, out of 11 million vaccines.
With the new reports, the rate of incidents with the AstraZeneca shot in the UK is around 1 in 600,000. There have been no reports of the same reactions to the vaccine from Pfizer Inc. and BioNTech SE, which is also used in Great Britain.
“Based on this ongoing review, the benefits of the Covid-19 vaccines continue to outweigh any risks and you should continue to be vaccinated when prompted,” the MHRA said. The AstraZeneca and Pfizer vaccines have shown “very high levels of protection” against Covid-19, the agency said, adding that “all vaccines and drugs have side effects.”
The UK has one of the fastest vaccination programs in the world, delivering vaccines to more than half of all adults by the end of March. New daily Covid cases and deaths have fallen to the lowest levels since September, even as infections rise again in much of the European Union, where vaccinations have been delayed.
Earlier this week, the European medicines regulator said a link between the AstraZeneca vaccine and a rare type of blood clot was possible, identifying at least 62 cases of the disease. The European Medicines Agency has said its safety committee will likely issue an updated recommendation next week.
Germany has banned young people from taking the AstraZeneca vaccine due to growing concerns about side effects. This follows reports of 31 cases of rare clots, mostly in women.
Norway and Denmark have extended suspensions on the use of the projectile, which has also been the subject of a scuffle over supplies between the EU, the UK and others.
Australia reported a case of bleeding disorders after AstraZeneca vaccine inoculation on Friday and is investigating, according to a joint statement from government agencies.
(Except for the title, this story was not edited by UK Time News staff and is posted Platforms.)